These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3912573)
1. [The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex]. Reshad K; Suzuki K; Inui K; Takahashi Y; Umemiya M; Nakano Y; Sakamoto M; Takeuchi Y; Shimada T Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1343-50. PubMed ID: 3912573 [No Abstract] [Full Text] [Related]
2. [Auxiliary value of TPA in diagnosing neoplastic diseases]. Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis]. Komatsu H Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of tumor markers in breast cancer patients]. Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907 [TBL] [Abstract][Full Text] [Related]
6. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion]. Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690 [No Abstract] [Full Text] [Related]
7. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms]. Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of CEA levels in lung cancer]. Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691 [TBL] [Abstract][Full Text] [Related]
9. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886 [TBL] [Abstract][Full Text] [Related]
10. [Beta 2 microglobulin and CEA in the blood and homogenate: comparison in neoplastic and non-neoplastic pulmonary pathology]. Abbasciano V; Felisatti G; Arcadi A; Abbasciano N; Ferroci V; Pittini S Riv Emoter Immunoematol; 1983; 30(3):271-81. PubMed ID: 6366997 [No Abstract] [Full Text] [Related]
11. [Diagnosis of tumors with the use of immunologic tumor markers]. Vorlaender KO Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301 [No Abstract] [Full Text] [Related]
12. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426 [TBL] [Abstract][Full Text] [Related]
13. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers]. Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169 [TBL] [Abstract][Full Text] [Related]
14. [Ferritin, CEA and TPA as tumor markers in breast neoplasms]. Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052 [TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer]. Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506 [No Abstract] [Full Text] [Related]
16. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid]. Loos U; Oehr P; Genske F; Schlack W Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571 [No Abstract] [Full Text] [Related]
17. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies]. Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295 [No Abstract] [Full Text] [Related]
18. [Distribution and prognostic value of CEA and TPA in cancer of the lung]. Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]. Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma]. Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]